Challenges in the care of individuals with severe primary insulin-like growth factor-I deficiency (SPIGFD): an international, multi-stakeholder perspective.
Backeljauw PF, Andrews M, Bang P, Dalle Molle L, Deal CL, Harvey J, Langham S, Petriczko E, Polak M, Storr HL, Dattani MT.
Orphanet J Rare Dis. 2023 Oct 7;18(1):312. doi: 10.1186/s13023-023-02928-7.
PMID:37805563
Insulin-like growth factor ternary complex components as biomarkers for the diagnosis of short stature.
Giannakopoulos A, Efthymiadou A, Chrysis D.
Eur J Endocrinol. 2021 Oct 8;185(5):629-635. doi: 10.1530/EJE-21-0475.
PMID:34403357
Short Stature due to Bioinactive Growth Hormone (Kowarski Syndrome).
Karaoglan M.
Endocr Pract. 2023 Nov;29(11):902-911. doi: 10.1016/j.eprac.2023.08.013. Epub 2023 Aug 30.
PMID:37657628
The role of neuronal insulin/insulin-like growth factor-1 signaling for the pathogenesis of Alzheimer's disease: possible therapeutic implications.
Zemva J, Schubert M.
CNS Neurol Disord Drug Targets. 2014 Mar;13(2):322-37. doi: 10.2174/18715273113126660141.